Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.9%

1 terminated out of 34 trials

Success Rate

93.8%

+7.2% vs benchmark

Late-Stage Pipeline

3%

1 trials in Phase 3/4

Results Transparency

27%

4 of 15 completed with results

Key Signals

4 with results94% success

Data Visualizations

Phase Distribution

29Total
Not Applicable (13)
Early P 1 (3)
P 1 (9)
P 2 (3)
P 4 (1)

Trial Status

Completed15
Recruiting9
Not Yet Recruiting5
Unknown2
Active Not Recruiting2
Terminated1

Trial Success Rate

93.8%

Benchmark: 86.5%

Based on 15 completed trials

Clinical Trials (34)

Showing 20 of 20 trials
NCT07425769Not ApplicableRecruiting

Adapting RDAD for DS

NCT07568041Phase 1Not Yet RecruitingPrimary

Phase 1 Study to Evaluate the Safety and Tolerability of 8M2D in Healthy People and Alzheimer's Patients

NCT05592678Not ApplicableRecruitingPrimary

δ in Dementia Clinical Trials

NCT07529015Not ApplicableNot Yet RecruitingPrimary

Acoustic Stimulation During Sleep: Effects on Memory and p-tau217 in MCI

NCT07341009RecruitingPrimary

Evaluation of a Neuropsychological Tool to Assess Temporal Processing Abilities in Alzheimer's Disease

NCT05558709Not ApplicableRecruitingPrimary

Social-cognitive Functioning: Validation of a New Neuropsychological Test

NCT07466394Not ApplicableRecruitingPrimary

COGSCREEN II: Early Detection of Cognitive Impairment

NCT02854033Completed

Alzheimer's Disease Neuroimaging Initiative 3

NCT06489015Early Phase 1Active Not RecruitingPrimary

Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials

NCT07458620Phase 1Not Yet RecruitingPrimary

Prospective Single-Arm Safety Study of Cervical LVA in AD Patients

NCT07419022Not ApplicableNot Yet RecruitingPrimary

Improv Music Therapy for Older Adults

NCT07417540Not ApplicableCompletedPrimary

Evaluation of SCALE PET Software for Quantitative Brain PET Analysis in Alzheimer's Disease

NCT07386808Not ApplicableActive Not RecruitingPrimary

Improvement of Sleep Disorders in Patients With Alzheimer's Disease After Sunlight Exposure Therapy.

NCT07380204Not ApplicableRecruiting

Quantification of Hsp90 in the Human Brain

NCT07307872CompletedPrimary

A Biomarker-chip Assay in Preserved Red Blood Cells for the Diagnosis of Alzheimer's Disease

NCT05291234Phase 2CompletedPrimary

A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's Disease

NCT05771428Phase 2CompletedPrimary

Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease

NCT07166744Not ApplicableNot Yet Recruiting

Contribution of Pathological Alpha-synuclein as a Diagnostic Biomarker for Dementia With Lewy Bodies

NCT06114745Phase 1CompletedPrimary

A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

NCT05059158RecruitingPrimary

Amyloid-β Clearance Mechanisms in Alzheimer's Disease

Scroll to load more

Research Network

Activity Timeline